BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36525255)

  • 1. The Settlement of the Blue Cross Blue Shield Antitrust Litigation: Creating a New Potential Catalyst for Health Insurance Industry Restructuring.
    Brennan T
    JAMA Health Forum; 2022 Dec; 3(12):e224737. PubMed ID: 36525255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on Kartell v. Blue Shield of Massachusetts, Inc.: an antitrust analysis of Blue Shield's reimbursement schemes.
    Wayne AB
    Am J Law Med; 1986; 11(4):465-500. PubMed ID: 3591810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the physical therapy benefit in a typical Blue Cross Blue Shield preferred provider organization plan available in the individual insurance market in 2011.
    Sandstrom RW; Lehman J; Hahn L; Ballard A
    Phys Ther; 2013 Oct; 93(10):1342-50. PubMed ID: 23641028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A competitive analysis of most favored nations clauses in contracts between health care providers and insurers.
    Celnicker A
    Spec Law Dig Health Care (Mon); 1991 Dec; (154):7-36. PubMed ID: 10115476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New England's Blue Cross Blue Shield shake-out: a case study in consumer activism.
    Sherman R
    States Health; 1999 Dec; 9(4):1-8. PubMed ID: 11503595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hospital response to Medicare's Prospective Payment System: an econometric model of Blue Cross and Blue Shield plans.
    Scheffler RM; Clement DG; Sullivan SD; Hu TW; Sung HY
    Med Care; 1994 May; 32(5):471-85. PubMed ID: 8182975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bounceback: Blues thrive as markets cool toward HMOs.
    Cunningham R; Sherlock DB
    Health Aff (Millwood); 2002; 21(1):24-38. PubMed ID: 11900082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ball Memorial Hospital: Section 2 Sherman Act analysis in the alternative health care delivery market.
    Kirsch T
    Am J Law Med; 1988; 14(2-3):249-79. PubMed ID: 3072878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Judge Posner's RFP: antitrust law and managed care.
    Sage WM
    Health Aff (Millwood); 1997; 16(6):44-61. PubMed ID: 9444808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high cost of fine print. Antitrust case against a major Blue Cross plan may redefine terms of contract negotiations.
    Evans M; Blesch G
    Mod Healthc; 2010 Oct; 40(43):6-7, 16, 1. PubMed ID: 21049792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Antitrust: Health Care And Health Insurance Market Trends And The Future Of Competition.
    Glied SA; Altman SH
    Health Aff (Millwood); 2017 Sep; 36(9):1572-1577. PubMed ID: 28874483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For-profit conversion and merger trends among Blue Cross Blue Shield health plans.
    Grossman JM; Strunk BC
    Issue Brief Cent Stud Health Syst Change; 2004 Jan; (76):1-6. PubMed ID: 14976992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine New Jersey hospitals charge Blue Cross with antitrust. Beth Israel Hospital et al. v. Blue Cross and Blue Shield of New Jersey, Inc.
    Hudson T
    Hosp Health Netw; 1993 Sep; 67(18):62. PubMed ID: 8369840
    [No Abstract]   [Full Text] [Related]  

  • 14. Questions about BCBS lawsuit Settlement.
    TMA
    Tenn Med; 2009 Jan; 102(1):9. PubMed ID: 19181123
    [No Abstract]   [Full Text] [Related]  

  • 15. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
    Levitt DM
    Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal. Experts debate the impact of antitrust suit against Michigan Blues.
    Taylor M
    Hosp Health Netw; 2010 Dec; 84(12):12, 14. PubMed ID: 21268792
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 18. On the line for Mich. Blues. Decision on 'most favored nation' clauses could affect federal litigation.
    Halcom C
    Mod Healthc; 2012 Jul; 42(31):18. PubMed ID: 22950228
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitrust enforcement in the medical services industry: what does it all mean?
    Havighurst CC
    Milbank Mem Fund Q Health Soc; 1980; 58(1):89-124. PubMed ID: 6903786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.